Physician

Kevin Eugene Sanders, MD

According to 2025 Medicare claims, Kevin Sanders, MD (NPI: 1376554154) practices radiation oncology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is SOUND CANCER CARE PLLC (NPI: 1487168324; TIN: 822830733) and primary practice location at 98373-1659. Sanders is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Sanders' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 552 traditional Medicare patients, billed 41,032 HCPCS/CPT codes, and received $3,940,941 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 120 prescription claims across 57 beneficiaries totaling $1,299 in drug costs, led by Oxycodone Hcl (Oxycodone Hcl). Open Payments data shows 23 records totaling $947. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $419,616 to $3,940,941. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,221 and ending at $1,299. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2015 Medicare payment: $419,616 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $459,385 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,836,960 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,440,008 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,880,084 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,166,087 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,190,992 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,940,941 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015751,296$419,616
2016N/RN/RN/R
2017N/RN/RN/R
2018702,443$459,385
20191769,167$1,836,960
202057136,354$2,440,008
202163252,944$2,880,084
202258345,496$4,166,087
202359946,855$5,190,992
202455241,032$3,940,941

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.8K$7.5K2015 Drug cost: $1,221 (USD; Tot_Drug_Cst)2016 Drug cost: $173 (USD; Tot_Drug_Cst)2017 Drug cost: $58 (USD; Tot_Drug_Cst)2018 Drug cost: $1,011 (USD; Tot_Drug_Cst)2019 Drug cost: $7,508 (USD; Tot_Drug_Cst)2020 Drug cost: $2,209 (USD; Tot_Drug_Cst)2021 Drug cost: $2,412 (USD; Tot_Drug_Cst)2022 Drug cost: $2,003 (USD; Tot_Drug_Cst)2023 Drug cost: $2,062 (USD; Tot_Drug_Cst)2024 Drug cost: $1,299 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151130$1,221
20161320$173
2017N/R17$58
2018N/R24$1,011
20194086$7,508
20202663$2,209
20214385$2,412
20224572$2,003
20235497$2,062
202457120$1,299

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78815Nuclear medicine study from skull base to mid-thigh with ct scan226266$1,201
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries189223$278
74177Ct scan of abdomen and pelvis with contrast167218$173
71260Ct scan of chest with contrast176229$53
Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml20123,205$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Oxycodone HclOxycodone Hcl11141$122
Tamsulosin HclTamsulosin Hcl141,170$87
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1794$76
Ciprofloxacin HclCiprofloxacin Hcl1133$31

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$947Elekta, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin Eugene Sanders, MD?

Tedicare shows public-source Medicare data for Kevin Eugene Sanders, MD (NPI 1376554154), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Eugene Sanders, MD have ACO affiliation data?

Kevin Eugene Sanders, MD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Kevin Eugene Sanders, MD?

Kevin Eugene Sanders, MD is linked to SOUND CANCER CARE PLLC (billing NPI 1487168324) in the available physician profile data.

Does Kevin Eugene Sanders, MD have Open Payments data?

Kevin Eugene Sanders, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.